Similar articles

• [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].

  Guzevatykh LS, Ostrovskaia RU, Gudasheva TA, Zaĭtseva NI, Voronina TA. Guzevatykh LS, et al. Eksp Klin Farmakol. 2002 Jan-Feb;65(1):3-6. Eksp Klin Farmakol. 2002. PMID: 12025780 Russian.
• Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.

  Yamasaki T, Kojima H, Sakurai T, Kasahara A, Watanabe S, Fujiwara M, Ueki S. Yamasaki T, et al. Arzneimittelforschung. 1981;31(4):701-7. Arzneimittelforschung. 1981. PMID: 6113833 No abstract available.
• The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.

  Khisti RT, Deshpande LS, Chopde CT. Khisti RT, et al. Psychopharmacology (Berl). 2002 May;161(2):120-8. doi: 10.1007/s00213-002-1006-5. Epub 2002 Mar 14. Psychopharmacology (Berl). 2002. PMID: 11981591
• Behavioral consequences of long-term treatment with neuroleptic drugs.

  Iversen SD, Howells RB, Hughes RP. Iversen SD, et al. Adv Biochem Psychopharmacol. 1980;24:305-13. Adv Biochem Psychopharmacol. 1980. PMID: 6105782 Review. No abstract available.
• Neuroleptic/dopamine receptors: elevation and reversal.

  List S, Seeman P. List S, et al. Adv Biochem Psychopharmacol. 1980;24:95-101. Adv Biochem Psychopharmacol. 1980. PMID: 6105811 Review. No abstract available.